These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 36876491)

  • 1. Functional Impairments Associated With ADHD in Adulthood and the Impact of Pharmacological Treatment.
    Kosheleff AR; Mason O; Jain R; Koch J; Rubin J
    J Atten Disord; 2023 May; 27(7):669-697. PubMed ID: 36876491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence to stimulants in adult ADHD.
    O'Callaghan P
    Atten Defic Hyperact Disord; 2014 Jun; 6(2):111-20. PubMed ID: 24604104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacological treatment of attention-deficit/hyperactivity disorder in adults].
    Rollini M; Baud P
    Rev Med Suisse; 2008 Jul; 4(165):1638-43. PubMed ID: 18767289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review.
    Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH
    CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of stimulants and atomoxetine on emotional lability in adults: A systematic review and meta-analysis.
    Moukhtarian TR; Cooper RE; Vassos E; Moran P; Asherson P
    Eur Psychiatry; 2017 Jul; 44():198-207. PubMed ID: 28646732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic, Clinical, and Sociodemographic Factors Associated With Stimulant Treatment Outcomes in ADHD.
    Brikell I; Wimberley T; Albiñana C; Pedersen EM; Vilhjálmsson BJ; Agerbo E; Demontis D; Børglum AD; Schork AJ; LaBianca S; Werge T; Mors O; Hougaard DM; Thapar A; Mortensen PB; Dalsgaard S
    Am J Psychiatry; 2021 Sep; 178(9):854-864. PubMed ID: 34154395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.
    Biederman J; Seidman LJ; Petty CR; Fried R; Doyle AE; Cohen DR; Kenealy DC; Faraone SV
    J Clin Psychiatry; 2008 Jul; 69(7):1150-6. PubMed ID: 18517288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult attention-deficit/hyperactivity disorder treatment and cardiovascular implications.
    Hammerness PG; Surman CB; Chilton A
    Curr Psychiatry Rep; 2011 Oct; 13(5):357-63. PubMed ID: 21698412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep in adults with attention deficit hyperactivity disorder (ADHD) before and during treatment with methylphenidate: a controlled polysomnographic study.
    Sobanski E; Schredl M; Kettler N; Alm B
    Sleep; 2008 Mar; 31(3):375-81. PubMed ID: 18363314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Practical, Evidence-informed Approach to Managing Stimulant-Refractory Attention Deficit Hyperactivity Disorder (ADHD).
    Cortese S; Newcorn JH; Coghill D
    CNS Drugs; 2021 Oct; 35(10):1035-1051. PubMed ID: 34403134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal executive function in attention deficit hyperactivity disorder: the effect of stimulant medication and age on spatial working memory.
    Barnett R; Maruff P; Vance A; Luk ES; Costin J; Wood C; Pantelis C
    Psychol Med; 2001 Aug; 31(6):1107-15. PubMed ID: 11513378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Personalized Remote Mobile Surveys of Adult ADHD Symptoms and Function: A Pilot Study of Usability and Utility for Pharmacology Monitoring.
    Surman C; Boland H; Kaufman D; DiSalvo M
    J Atten Disord; 2022 May; 26(7):1001-1010. PubMed ID: 34693788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADHD (ATTENTION DEFFICIT HYPERACTIVITY DISORDER)--A TROUBLING ENTITY, SOMETIMES PERPETUATING DURING ADULT LIFE.
    Amihăesei IC; Zamfir CL
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):10-4. PubMed ID: 27125066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
    Kordon A; Kahl KG
    Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD).
    NIH Consens Statement; 1998 Nov 16-18; 16(2):1-37. PubMed ID: 10868163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescents.
    Sikirica V; Haim Erder M; Xie J; Macaulay D; Diener M; Hodgkins P; Wu EQ
    Pharmacoeconomics; 2012 Aug; 30(8):e1-15. PubMed ID: 22788263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of pharmacotherapies for attention-deficit hyperactivity disorder in adults.
    Santosh PJ; Sattar S; Canagaratnam M
    CNS Drugs; 2011 Sep; 25(9):737-63. PubMed ID: 21870887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of attention deficit hyperactivity disorder in adults].
    Ramos-Quiroga JA; Chalita PJ; Vidal R; Bosch R; Palomar G; Prats L; Casas M
    Rev Neurol; 2012 Feb; 54 Suppl 1():S105-15. PubMed ID: 22374761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.